Resveratrol Protects against Sepsis-Associated Encephalopathy and Inhibits the NLRP3/IL-1 β Axis in Microglia

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Sui, Da Ming ^a,b   Xie, Qun ^a   Yi, Wen Jing ^a   Gupta, Sahil ^c,d   Yu, Xi Ya ^a   Li, Jin Bao ^a   Wang, Jun ^a   Wang, Jia Feng ^a   Deng, Xiao Ming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b CHENGDU MILITARY GENERAL HOSPITAL   (China)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CRYOPYRIN; INTERLEUKIN 1BETA; RESVERATROL; NLRP3 PROTEIN, MOUSE; STILBENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; HIPPOCAMPUS; IN VITRO STUDY; INFLAMMATION; LOW DRUG DOSE; MALE; MICROGLIA; MORRIS WATER MAZE TEST; MOUSE; NEUROPHARMACOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SEPSIS ASSOCIATED ENCEPHALOPATHY; SPATIAL LEARNING; SPATIAL MEMORY; TREATMENT OUTCOME; ANIMAL; C57BL MOUSE; CELL LINE; METABOLISM;

ANIMALS; CELL LINE; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; RESVERATROL; SEPSIS-ASSOCIATED ENCEPHALOPATHY; STILBENES;

EID: 84958291863     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/1045657     Document Type: Article

References (36)

1. G. S. Martin, D. M. Mannino, S. Eaton, and M. Moss, "The epidemiology of sepsis in the United States from 1979 through 2000," The New England Journal of Medicine, vol. 348, no. 16, pp. 1546-1554, 2003.
2. S. Cotena and O. Piazza, "Sepsis-associated encephalopathy," Translational Medicine @ UniSa, vol. 2, pp. 20-27, 2012.
3. T. E. Gofton and G. B. Young, "Sepsis-associatedencephalopathy," Nature Reviews Neurology, vol. 8, no. 10, pp. 557-566, 2012.
4. L.-N. Zhang, X.-T. Wang, Y.-H. Ai et al., "Epidemiological features and risk factors of sepsis-associated encephalopathy in intensive care unit patients: 2008-2011," Chinese Medical Journal, vol. 125, no. 5, pp. 828-831, 2012.
5. A. W. Lemstra, J. C. M. Groen in't Woud, J. J. M. Hoozemans et al., "Microglia activation in sepsis: a case-control study," Journal of Neuroinflammation, vol. 4, article 4, 2007.
6. Y. Imamura, H. Wang, N. Matsumoto et al., "Interleukin-1β causes long-term potentiation deficiency in a mouse model of septic encephalopathy," Neuroscience, vol. 187, pp. 63-69, 2011.
7. F. Mina, C. M. Comim, D. Dominguini et al., "Il1-β involvement in cognitive impairment after sepsis," Molecular Neurobiology, vol. 49, no. 2, pp. 1069-1076, 2014.
8. C. A. Moraes, G. Santos, T. C. L. de Sampaio e Spohr et al., "Activated microglia-induced deficits in excitatory synapses through IL-1beta: implications for cognitive impairment in sepsis,"Molecular Neurobiology, vol. 52, no. 1, pp. 653-663, 2015.
9. E. Park and J. M. Pezzuto, "The pharmacology of resveratrol in animals and humans," Biochimica et Biophysica Acta, vol. 1852, no. 6, pp. 1071-1113, 2015.
10. M. Pallàs, D. Porquet, A. Vicente, and C. Sanfeliu, "Resveratrol: new avenues for a natural compound in neuroprotection," Current Pharmaceutical Design, vol. 19, no. 38, pp. 6726-6731, 2013.
11. L. Smeding, H. Leong-Poi, P. Hu et al., "Salutary effect of resveratrol on sepsis-induced myocardial depression," Critical Care Medicine, vol. 40, no. 6, pp. 1896-1907, 2012.
12. J. H. Holthoff, Z. Wang, K. A. Seely, N. Gokden, and P. R. Mayeux, "Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury," Kidney International, vol. 81, no. 4, pp. 370-378, 2012.
13. Y. Yao, J. Li, Y. Niu et al., "Resveratrol inhibits oligomeric Aβ-induced microglial activation via NADPH oxidase," Molecular Medicine Reports, vol. 12, no. 4, pp. 6133-6139, 2015.
14. M. Kodali, V. K. Parihar, B. Hattiangady, V. Mishra, B. Shuai, and A. K. Shetty, "Resveratrol prevents age-related memory and mood dysfunction with increased hippocampal neurogenesis and microvasculature, and reduced glial activation," Scientific Reports, vol. 5, article 8075, 2015.
15. X.-J. Li, H.-Y. Fu, W.-J. Yi et al., "Dual role of leukotriene B4 receptor type 1 in experimental sepsis," Journal of Surgical Research, vol. 193, no. 2, pp. 902-908, 2015.
16. J.-F. Wang, J.-B. Li, Y.-J. Zhao et al., "Up-regulation of programmed cell death 1 ligand 1 on neutrophils may be involved in sepsis-induced immunosuppression: an animal study and a prospective case-control study," Anesthesiology, vol. 122, no. 4, pp. 852-863, 2015.
17. D. Ito, Y. Imai, K. Ohsawa, K. Nakajima, Y. Fukuuchi, and S. Kohsaka, "Microglia-specific localisation of a novel calcium binding protein, Iba1," Molecular Brain Research, vol. 57, no. 1, pp. 1-9, 1998.
18. M.-S.Tan, J.-T. Yu, T. Jiang, X.-C. Zhu, and L. Tan, "The NLRP3 inflammasome in Alzheimer's disease," Molecular Neurobiology, vol. 48, no. 3, pp. 875-882, 2013.
19. K. B. Koronowski, K. R. Dave, I. Saul et al., "Resveratrol preconditioning induces a novel extended window of ischemic tolerance in the mouse brain," Stroke, vol. 46, no. 8, pp. 2293- 2298, 2015.
20. S. V. Narayanan, K. R. Dave, I. Saul, and M. A. Perez-Pinzon, "Resveratrol preconditioning protects against cerebral ischemic injury via nuclear erythroid 2-related factor 2," Stroke, vol. 46, no. 6, pp. 1626-1632, 2015.
21. C. Pang, L. Cao, F. Wu et al., "The effect of trans-resveratrol on post-stroke depression via regulation of hypothalamus-pituitary-adrenal axis," Neuropharmacology, vol. 97, pp. 447-456, 2015.
22. A. Y. Sun, Q. Wang, A. Simonyi, and G. Y. Sun, "Resveratrol as a therapeutic agent for neurodegenerative diseases," Molecular Neurobiology, vol. 41, no. 2-3, pp. 375-383, 2010.
23. D. Porquet, G. Casadesús, S. Bayod et al., "Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8," Age, vol. 35, no. 5, pp. 1851-1865, 2013.
24. F. Jin, Q. Wu, Y.-F. Lu, Q.-H. Gong, and J.-S. Shi, "Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats," European Journal of Pharmacology, vol. 600, no. 1-3, pp. 78-82, 2008.
25. A. V. Witte, L. Kerti, D. S. Margulies, and A. Flöel, "Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults," Journal of Neuroscience, vol. 34, no. 23, pp. 7862-7870, 2014.
26. M. Michels, L. G. Danielski, F. Dal-Pizzol, and F. Petronilho, "Neuroinflammation: microglial activation during sepsis," Current Neurovascular Research, vol. 11, no. 3, pp. 263-270, 2014.
27. C. J. Henry, Y. Huang, A. M. Wynne, and J. P. Godbout, "Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokines," Brain, Behavior, and Immunity, vol. 23, no. 3, pp. 309-317, 2009.
28. M. T. Heneka, M. P. Kummer, A. Stutz et al., "NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice," Nature, vol. 493, no. 7434, pp. 674-678, 2013.
29. S. E. Hickman, E. K. Allison, and J. El Khoury, "Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's disease mice," Journal of Neuroscience, vol.28, no. 33, pp. 8354-8360, 2008.
30. Y. P. Chang, S. M. Ka, W. H. Hsu et al., "Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy," Journal of Cellular Physiology, vol. 230, no. 7, pp. 1567-1579, 2015.
31. J. Ye, Z. Liu, J. Wei et al., "Protective effect of SIRT1 on toxicity of microglial-derived factors induced by LPS to PC12 cells via the p53-caspase-3-dependent apoptotic pathway," Neuroscience Letters, vol. 553, pp. 72-77, 2013.
32. Y. Fu, Y. Wang, L. Du et al., "Resveratrol inhibits ionising irradiation-induced inflammation in MSCs by activating Sirt1 and limiting NLRP-3 inflammasome activation," International Journal of Molecular Sciences, vol. 14, no. 7, pp. 14105-14118, 2013.
33. J. A. Garcia, H. Volt, C. Venegas et al., "Disruption of the NF-B/NLRP3 connection by melatonin requires retinoid-related orphan receptor- and blocks the septic response in mice," The FASEB Journal, vol. 29, no. 9, pp. 3863-3875, 2015.
34. K. Matsui, S. Ezoe, K. Oritani et al., "NAD-dependent histone deacetylase, SIRT1, plays essential roles in the maintenance of hematopoietic stem cells," Biochemical and Biophysical Research Communications, vol. 418, no. 4, pp. 811-817, 2012.
35. T. Misawa, T. Saitoh, T. Kozaki, S. Park, M. Takahama, and S. Akira, "Resveratrol inhibits the acetylated α-tubulin-mediated assembly of the NLRP3-inflammasome," International Immunology, vol. 27, no. 9, pp. 425-434, 2015.
36. S.-H. Cho, J. A. Chen, F. Sayed et al., "SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1β," The Journal of Neuroscience, vol. 35, no. 2, pp. 807-818, 2015.